Karolinska Institutet
Browse

Engineered extracellular vesicles for biomedical applications

Download (2.32 MB)
thesis
posted on 2024-09-02, 22:19 authored by Dhanu GuptaDhanu Gupta

Nature's very own nanoparticle, Extracellular vesicles (EVs), are lipid membrane-enclosed vesicles encapsulated with diverse biomolecules and are actively secreted by all cell types for intercellular communication. The unique properties of EVs, such as stability in circulation, biocompatibility, immune tolerance, and the ability to cross biological barriers, render EVs a next-generation drug delivery tool. Therapeutic EV research has seen tremendous development in the past decade, from in vitro studies towards pre-clinical models to various clinical trials. Even so, the road towards successful clinical translation has faced various hurdles primarily due to the lack of technology to address the knowledge gap in EV biology. Hence, this thesis is focused on addressing some of these critical challenges and exploring novel biomedical applications for EVs.

EVs are considered as essential mediators in physiology and disease pathology. However, to elucidate their important role in pathophysiology or as therapeutics, sensitive tools for visualising them are much needed. Here, in paper I, we have developed a sensitive bioluminescent labelling system for tracking EVs in vitro and in vivo. By genetically modifying the producer cells with EV-associated tetraspanins-fusions, we could efficiently load luciferase enzymes (Nanoluciferase and Thermoluciferase) into EVs. Utilising the Nanoluciferase labelling system, we could detect as low as 5000 EVs in a solution, and the naked eye could visualise the luminescence generated from these EVs. With this level of sensitivity, we explored various in vivo applications and observed that exogenous EVs are rapidly distributed throughout the body, primarily to the liver, lung, and spleen. In addition, we identified that EV subpopulations differ in their in vivo biodistribution profile. In summary, this system allows for highly sensitive detection of EVs in vivo and reflects the true fate of EVs.

Despite tremendous advancement in understanding EV biology or engineering, techniques to surface engineer EVs with large protein biotherapeutics without altering their innate properties are largely lacking. Here in paper II, we developed a novel surface display technology for EVs, which allows for efficient display of several membrane proteins on the EV surface simultaneously. Using this platform, we decorated EVs' surface with cytokine receptors that can decoy pro-inflammatory cytokines such as TNF-α or IL-6/sIL-6R complexes. These cytokine decoy EVs were more active than a clinically approved biologic against TNF-α in vitro. Importantly, these cytokine decoy EVs ameliorated the disease phenotype in three different mice inflammation models, including neuroinflammation. In paper III, we have applied interleukin 6 signal transducer (IL-6ST) decoy EVs to tackle inflammation in muscle pathologies to enhance the muscle regeneration process. Using decoy EVs as a therapeutic intervention in mdx mice mimicking Duchene Muscular Dystrophy (DMD), we could achieve significant downregulation of phosphorylation of the proinflammatory transcription factor STAT3 in muscles.

In conclusion, the tools developed in this thesis, from highly sensitive detection of EV subtype to efficient display of biotherapeutics cargo on EV surfaces, holds great future potential and applicability in numerous biomedical applications of EVs.

List of scientific papers

I. Gupta D*, Liang X*, Pavlova S, Wiklander OPB, Corso G, Zhao Y, Saher O, Bost J, Zickler AM, Piffko A, Maire CL, Ricklefs FL, Gustafsson O, Llorente VC, Gustafsson MO, Bostancioglu RB, Mamand DR, Hagey DW, Görgens A, Nordin JZ, El Andaloussi S. Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging. J Extracell Vesicles. 2020;9(1):1800222. *These authors contributed equally.
https://doi.org/10.1080/20013078.2020.1800222

II. Gupta D*, Wiklander OPB*, Görgens A, Conceição M, Corso G, Liang X, Seow Y, Balusu S, Feldin U, Bostancioglu B, Jawad R, Mamand DR, Lee YXF, Hean J, Mäger I, Roberts TC, Gustafsson M, Mohammad DK, Sork H, Backlund A, Lundin P, de Fougerolles A, Smith CIE, Wood MJA, Vandenbroucke RE, Nordin JZ, El-Andaloussi S. Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles. Nat Biomed Eng. 2021;5(9):1084-1098. *These authors contributed equally.
https://doi.org/10.1038/s41551-021-00792-z

III. Conceição M, Forcina L, Wiklander OPB, Gupta D, Nordin JZ, Vrellaku B, McClorey G, Mäger I, Gӧrgens A, Lundin P, Musarò A, Wood MJA, Andaloussi SE, Roberts TC. Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle. Biomaterials. 2021;266:120435.
https://doi.org/10.1016/j.biomaterials.2020.120435

History

Defence date

2022-01-21

Department

  • Department of Laboratory Medicine

Publisher/Institution

Karolinska Institutet

Main supervisor

El Andaloussi, Samir

Co-supervisors

Smith, Edvard

Publication year

2021

Thesis type

  • Doctoral thesis

ISBN

978-91-8016-402-3

Number of supporting papers

3

Language

  • eng

Original publication date

2021-12-28

Author name in thesis

Gupta, Dhanu

Original department name

Department of Laboratory Medicine

Place of publication

Stockholm

Usage metrics

    Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC